Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (19)

2023

  1. In pursuit of full recovery in major depressive disorder

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 273, Núm. 5, pp. 1095-1104

2022

  1. Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study

    Frontiers in Neurology, Vol. 13

  2. Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study

    Journal of Affective Disorders, Vol. 300, pp. 99-108

2021

  1. Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e22

  2. Is processing speed a valid neurocognitive endophenotype in bipolar disorder? Evidence from a longitudinal, family study

    Journal of Psychiatric Research, Vol. 141, pp. 241-247

2020

  1. Prevalence of depressive symptoms and suicidal ideation among Spanish medical students

    Actas Espanolas de Psiquiatria, Vol. 48, Núm. 4, pp. 154-162

  2. Virtual meetings and social isolation in covid-19 times: Transposable barriers

    Trends in Psychiatry and Psychotherapy

2019

  1. Neurocognitive endophenotypes in schizophrenia and bipolar disorder: A systematic review of longitudinal family studies

    Schizophrenia Research, Vol. 210, pp. 21-29

2018

  1. Tobacco smoking and its association with cognition in first episode psychosis patients

    Schizophrenia Research, Vol. 192, pp. 269-273

2015

  1. International Society for Nutritional Psychiatry Research consensus position statement: Nutritional medicine in modern psychiatry

    World Psychiatry

  2. Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review)

    Experimental and Therapeutic Medicine, Vol. 9, Núm. 3, pp. 643-652

2012

  1. Pharmacological approaches in bipolar disorders and the impact on cognition: A critical overview

    Acta Psychiatrica Scandinavica, Vol. 126, Núm. 5, pp. 315-331

2011

  1. Is Personal and social functioning associated with Subjective quality of life in schizophrenia patients living in the community?

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 261, Núm. 7, pp. 509-517

  2. O impacto da história de sintomas psicóticos na função cognitiva de doentes bipolares eutímicos: Comparação com doentes esquizofrênicos e controles saudáveis

    Revista Brasileira de Psiquiatria, Vol. 33, Núm. 4, pp. 353-361

  3. Symptomatic remission in schizophrenia patients: Relationship with social functioning, quality of life, and neurocognitive performance

    Schizophrenia Research, Vol. 129, Núm. 2-3, pp. 133-136

2010

  1. The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia

    BMC Psychiatry, Vol. 10

2009

  1. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients

    Psychiatry Research, Vol. 169, Núm. 3, pp. 220-228

2008

  1. Evidence for association between structural variants in lissencephaly-related genes and executive deficits in schizophrenia or bipolar patients from a Spanish isolate population

    Psychiatric Genetics, Vol. 18, Núm. 6, pp. 313-317

  2. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up

    Journal of Affective Disorders, Vol. 109, Núm. 3, pp. 286-299